Psychiatrist Video Statistics

Key takeaways

1. Psychiatrists and psychiatric practices made 16.6% of the 451 on-topic videos among YouTube’s most-viewed results for ‘psychiatrist’, ‘ADHD medication’ and ‘depression’ and drew 8.2% of their views; media, news, podcast and general-creator channels drew 51.5% (our read, Nov 9, 2026). (Mark Studios) See details
2. Off-topic or counted-only videos drew 50.4% of the sample’s views. In the ‘depression’ list they were 47.3% of videos and drew 57.2% of views: songs titled ‘Depression’, comedy sketches, Great Depression history and similar (our read, Nov 9, 2026). (Mark Studios) See details
3. The 15 U.S.-placed psychiatrist and psychiatric-practice channels drew 4.3% of the on-topic views. One channel named a Florida place, a practice whose own text lists Delray, Florida, in Palm Beach County, and its one sampled video had 86,560 views (our read, Nov 9, 2026). (Mark Studios) See details
4. Those 15 U.S.-placed psychiatrist channels posted 3,512 videos in the year to Nov 9, 2026, a median of 97 per channel; four posted nothing and the busiest posted 971 (our read). (Mark Studios) See details
5. CMS listed 19,778 providers of type ‘Psychiatry’ billing Medicare Part B fee-for-service in 2024, 10.1% fewer than the 21,988 in 2019. Medicare paid them $655,694,331 in 2024, down 19.6% before inflation (our sums of CMS’s file). (CMS) See details
6. In Palm Beach, Broward and Martin counties, 97, 105 and 10 psychiatrists billed Medicare in 2024, 19.4% of Florida’s 1,093 (our count from CMS’s file). (CMS) See details
7. BLS estimated 27,980 wage and salary psychiatrist jobs in May 2025, with a median annual wage of $281,870. Florida had 1,930 jobs and a median of $316,200; the Miami-Fort Lauderdale-West Palm Beach area’s median was $403,430. (BLS) See details
8. In the AMA’s 2024 Physician Practice Benchmark Survey, 85.9% of psychiatrists had given a video visit in the prior week and 56.9% gave more than a fifth of their visits by video, against 9.3% of all physicians. In the AMA’s analysis of 2024 Medicare claims, 31.2% of psychiatrists’ telehealth-eligible charges were billed as telehealth. (AMA) See details
9. Private offices of psychiatrists numbered 16,840 in 2025, up 63.6% from 10,291 in 2015 (BLS QCEW), and 78.9% of employer offices reported telemedicine revenue in the 2022 Economic Census. (BLS and Census) See details
10. In 2024, 22.9% of U.S. adults received mental health treatment, 16.7% took prescription medication for their mental health and 12.8% were treated by telehealth. NSDUH does not count psychiatrist visits on their own: 9.9% were treated in the office of a therapist, psychologist, psychiatrist or other mental health professional. (SAMHSA) See details
11. In a 2022 study of the 100 most popular TikTok videos about ADHD, clinician raters judged 52% misleading (Yeung et al., Canadian Journal of Psychiatry). (Canadian Journal of Psychiatry) See details
12. The “90% of people who die by suicide had a mental illness” figure comes from psychological autopsy studies: a 2003 review found a median 91% across 54 case series. CDC’s 2018 Vital Signs found 54% of people who died by suicide in 27 states in 2015 had no known mental health condition; AFSP points out that this measure counts unknown and missing entries as none. (Psychological Medicine and CDC) See details

What psychiatry videos get the most views on YouTube?

Psychiatrists and psychiatric practices drew 8.2% of the on-topic views when we read YouTube's 200 most-viewed results for each of 'psychiatrist', 'ADHD medication' and 'depression' on November 9, 2026 (our calculation). Media, news, podcast and general-creator channels drew 51.5%. We pulled the three view-sorted lists through the YouTube Data API on one day, with no country filter, and got 571 unique videos from 386 channels with 1,664,154,230 lifetime views in all (our calculation). The lists are YouTube's own ranking on that day, not a census, and view counts are lifetime snapshots. We classed every channel by hand from its own title, description and sample titles; we did not check anyone's credentials.

Much of what the searches return is not about psychiatry. 21.0% of the videos were off-topic or counted-only, and they drew 50.4% of all views (our calculation). The 'depression' list was the noisiest: 47.3% of its videos and 57.2% of its views were off-topic or counted-only. For 'psychiatrist' the figures were 13.1% of videos and 35.8% of views, and for 'ADHD medication' 2.6% and 32.9% (our calculation). The off-topic videos were mostly songs and albums (45 videos, most titled 'Depression'), scripted sketches and skits (45, many of them Indian shorts that use 'depression' as slang) and Great Depression history and recipes (12). A further 7 videos came from ASMR roleplay channels; we counted them and did not open them. That left 451 on-topic videos.

We found 31 psychiatrist or psychiatric-practice channels. They posted 16.6% of the on-topic videos (our calculation). Their share of views was highest in the 'psychiatrist' list (16.6%), lower for 'ADHD medication' (8.8%) and lowest for 'depression' (3.5%). One channel, HealthyGamerGG, whose own titles describe its host as a psychiatrist, drew 34.9% of the psychiatrist class's views (our calculation). Other clinicians, such as psychologists, licensed therapists, nurse practitioners, pharmacists and doctors of other specialties, posted 63 on-topic videos and drew 14.1% of on-topic views. Media channels posted 176 on-topic videos. Personal and family stories, 85 videos, drew 13.3% of on-topic views; we publish them as counts only (our calculation).

Views are concentrated. The largest channel, Doctor Myro, an anesthesiologist's channel, drew 6.0% of on-topic views with one short video on what depression can look like. The three largest channels drew 14.1% and the ten largest 34.2% (our calculation; no ties at rank 3 or 10). Short videos did well: 29.0% of on-topic videos ran 60 seconds or less, and they drew 42.9% of on-topic views. 1 video was marked made for kids by its uploader, and 0 carried YouTube's altered or synthetic content flag in the API read (our calculation).

U.S. psychiatrists made up about half of the psychiatrist channels but drew a small share of views. 15 psychiatrist or practice channels were U.S.-placed (own text names a U.S. place, or the country setting is the United States), and they drew 4.3% of on-topic views; India-placed psychiatrist channels drew 3.0% (our calculation). 1 channel named a Florida place. Its one video in the sample had 86,560 views. No channel in the sample named Broward or Martin County, and no channel placed only in Florida appeared.

We then read a year of uploads from the U.S.-placed psychiatrist channels (our calculation; youtube-us-psychiatrist-channels.csv). They posted 3,512 videos in the year to November 9, 2026. The median channel posted 97, and 4 posted nothing. Dr. Josef, a tapering-clinic founder's channel, posted 971, and the three busiest posted 64.7% of the group's uploads. Our API budget ran out before the views of the two busiest posters were read, so the view figures cover the other channels only: their median upload had 4,463 views on the read date, and 56.3% of their uploads ran 60 seconds or less.

Privacy: 60 channels (personal stories, family stories and ASMR roleplay) appear as class and counts only, with no names, links or titles. In all 105 videos are withheld, including single videos in named channels that show a child or teen, name a private person's mental-health story or are age-restricted. Withheld videos drew 16.5% of on-topic views; their views are blank in the public files, so totals rebuilt from those files come out lower (our calculation). Data: youtube-videos.csv and youtube-channels.csv.

What do studies find about ADHD, depression and medication videos on YouTube and TikTok?

Much of the popular ADHD content is rated misleading. In a 2022 study of the 100 most popular TikTok videos about ADHD, clinician raters classified 52% as misleading, and non-clinicians posted most of the misleading ones (Canadian Journal of Psychiatry, Yeung et al.). Our mental health practice page sets that study beside the autism, OCD and #mentalhealth studies. The table lists the studies that rated psychiatric topics. Each is a snapshot of top-ranked or most-liked videos, scored by two or three raters.

Useful #adhdtest videos drew only 4% of the likes in the 2024 sample (Australasian Psychiatry, Verma and Sinha). In the 2025 ADHD study, 36.7% of 600 sampled comments on six videos resonated with the behaviours shown (JMIR Infodemiology, Sieferle et al.). A 2025 study of 80 YouTube videos and 85 websites on depression found 50% of the content matched ICD or DSM criteria (Journal of Mental Health, Gogoi et al.).

Who makes the videos depends on the platform and the language. In the 2018 sample of 159 YouTube ADHD videos, individual physicians or psychiatrists uploaded 16.98% (BMC Research Notes, Thapa et al.). In a 2026 study of 67 YouTube ADHD videos, doctors were the largest group at 31.3% (National Medical Journal of India, Iqbal et al.). On the Chinese TikTok (Douyin), psychiatrists published 39.7% of 121 depression videos in a 2026 study (Scientific Reports, Lin et al.). Experts made 72.63% of 95 Douyin videos on adolescent depression in a 2025 study (Frontiers in Public Health, Wang et al.). In a 2024 study of 58 Arabic-language YouTube videos on bipolar disorder, physicians made 33% (Saudi Pharmaceutical Journal, Alsabhan et al.). Health professionals were the largest source of 123 TikTok schizophrenia videos in a 2024 study, with 45 videos (Scientific Reports, Zhang et al.).

Clinicians' videos usually scored higher on quality scales, but they did not always draw more engagement. In a 2026 study of 164 ADHD videos on Douyin and Bilibili, healthcare professionals' videos had the highest Global Quality Score, 3.65 out of 5 (Digital Health, Yu et al.). Videos with a higher self-diagnosis risk drew more likes (r = 0.45), and quality was not linked to engagement (Yu et al.). Psychiatrists' depression videos on Douyin had a median Global Quality Score of 2.5, above the sample as a whole, and drew more engagement (Lin et al.). In the 2026 TikTok depression study, accuracy did not differ significantly between medical professionals and other creators and did not predict engagement; emotional appeals did (B = 0.73) (JMIR Infodemiology, Rainer et al.). In a 2024 study of 100 TikTok videos on depression or anxiety, each with at least a million views, anxiety was the topic of 57%, and personal-experience videos drew more engagement than videos from healthcare professionals (Journal of Adolescent Health, Samuel et al.). The JAMA benchmark score of the 2024 schizophrenia videos was correlated with likes (r = 0.721) (Zhang et al.). On YouTube in 2017, accurate schizophrenia videos had view counts similar to inaccurate ones (290,048 against 186,124) (Psychiatric Services, Nour et al.).

Medication videos are mostly told from the patient's side. A 2025 analysis of 548 TikTok videos about prescription stimulants found they averaged over 300,000 views each and portrayed the medicines mostly positively; the authors suggest this may influence demand much as direct-to-consumer advertising does (Journal of Attention Disorders, Johnson et al.). Of 99 TikTok videos on SSRIs collected on December 8, 2024, 35% named a specific SSRI and medical and nonmedical creators made roughly even numbers of videos (JMIR Mental Health, Quinn et al.). Nonmedical creators drew more total views (P = .01), and both groups dwelt on negative side effects (Quinn et al.). None of these studies measured what viewers did after watching, and we found no study of what a psychiatric practice's own videos do for appointments or treatment.

Does psychiatric care by video work as well as in person?

In randomised trials, symptom outcomes are about the same. A 2023 meta-analysis of 32 randomised trials with 3,592 participants across 11 mental illnesses found no significant difference in symptom improvement between telepsychiatry and face-to-face treatment when all diagnoses were combined (P = 0.248) (British Journal of Psychiatry, Hagi et al.). Dropout did not differ either (P = 0.564) (Hagi et al.). Results varied by disorder: telepsychiatry did better for depressive disorders in six studies and worse for eating disorders in one (Hagi et al.). Trials of psychotherapy by video are on our mental health practice page.

Older trials of psychiatrists' own work point the same way. In a 2007 Ontario trial, 495 patients referred for psychiatric consultation were randomised to face-to-face or telepsychiatry care, and outcomes and satisfaction were equivalent (Psychiatric Services, O'Reilly et al.). Telepsychiatry cost at least 10% less per patient, counting only the cost of the clinical service (O'Reilly et al.). In a 2004 VA trial of 119 veterans with depression treated with medication, psychoeducation and brief counselling, depression scores, adherence and satisfaction did not differ (American Journal of Psychiatry, Ruskin et al.). Video cost more per session until psychiatrists' travel to clinics more than 22 miles away was counted (Ruskin et al.).

In a 2013 trial at rural federally qualified health centers, 364 patients with depression who got collaborative care from an off-site team, including a psychiatrist by video, had higher odds of response (odds ratio 7.74) than patients in practice-based care (American Journal of Psychiatry, Fortney et al.). The authors credit closer adherence to the care model, not video alone. In the 2021 SPIRIT trial, 1,004 primary care patients with PTSD or bipolar disorder at clinics without on-site psychiatrists got either telepsychiatry collaborative care or referral to telepsychiatrists and telepsychologists (JAMA Psychiatry, Fortney et al.). The 12-month mental health scores did not differ significantly (P = .28), and both groups improved (Fortney et al.); the journal published three corrections to the paper in 2023. In the 2015 CATTS trial, 223 children with ADHD in seven communities improved more when child psychiatrists managed medication by video, with caregiver training in person, than in primary care with one telepsychiatry consultation (Journal of the American Academy of Child and Adolescent Psychiatry, Myers et al.). A 2025 trial in China of 80 patients with early-phase schizophrenia found video-based rehabilitation as effective as face-to-face sessions (Early Intervention in Psychiatry, Zhou et al.).

Outside trials, the evidence is observational. Among 120,050 Medicare beneficiaries with schizophrenia or bipolar I disorder (JAMA Health Forum, Wilcock et al.), patients of practices with the highest telemedicine use in the pandemic's first year had 13.0% more mental health visits per year and no differential change in medication adherence (Wilcock et al.). In a Kaiser Permanente study of adults with new depression diagnosed in primary care from March 2020 to May 2021, video visits had 37% lower odds of a follow-up visit with the prescriber than in-person visits (The Permanente Journal, Metrikin et al.). Telephone visits had 64% higher odds of an antidepressant being prescribed, but those prescriptions were less often dispensed (Metrikin et al.). In a VA cohort of recently separated veterans from 2020 to 2021, virtual visits averaged 44.6% of mental health visits, and a higher virtual share was associated with fewer suicide-related events in an instrumental-variable analysis (JAMA Network Open, Tenso et al.). Among VA mental health clinicians who delivered 26 million visits, a higher video share went with fewer clinic days and lower turnover (Health Affairs Scholar, Song et al.).

How much psychiatric care now happens by telehealth?

About two in five Medicare mental health claims. Among 9,548,926 Medicare fee-for-service beneficiaries with outpatient mental health visits, telehealth made up 2.1% of outpatient mental health claims before the pandemic and 42.9% from 2021 to 2023 (JAMA Network Open, McBain et al.). For depression, the share was 44.2% after the pandemic (McBain et al.). In the 2021-2022 Medical Expenditure Panel Survey, 27.8% of adult mental health outpatients got all their care by telehealth and about half all in person (JAMA Psychiatry, Olfson et al.). Patients on medication alone were less often all-telehealth (15.4%) than patients in psychotherapy without medication (41.6%) (Olfson et al.). In 2021-2022 commercial claims, 32.9% of 937,711 behavioral health episodes of care were telehealth only, and episodes with nonpsychiatrist providers were less likely to be (Psychiatric Services, Sowa et al.). Survey counts of adults using telehealth for mental health are on the mental health practice page.

Fewer psychiatrists went fully virtual than other specialists. Of 51,309 mental health specialists in commercial and Medicare Advantage claims, 13.0% were telemedicine-only in 2022, and the adjusted rate was lowest for psychiatrists, at 9.1% (JAMA Health Forum, Hailu et al.). In Medicare, specialists with the highest telemedicine use had only 0.88 percentage points more visits with rural patients by 2023 than the lowest users (JAMA Network Open, Jorem et al.). Their share of new patients changed by -3.55 percentage points against the lowest users (Jorem et al.).

Do psychoeducation videos change what patients think or do?

They shift stated attitudes more reliably than behaviour, and some trials find no effect. In a 2019 online trial of 556 U.S. adults who screened positive for depression, willingness to receive ECT rose from 31% to 63% after a psychoeducation video, about the same gain as after a brochure (Psychiatric Services, Tsai et al.). In a 2021 trial, a 90-second video of a young woman with schizophrenia reduced stigma among 1,055 adults aged 18 to 30 more than a written vignette, and the effect lasted to 30 days (American Journal of Psychiatry, Amsalem et al.); the trial measured attitudes, not behaviour. In a 2025 trial by French researchers, a 3-minute video of a psychiatrist or of a patient did not significantly change 147 young adults' attitudes towards seeking mental health care (Early Intervention in Psychiatry, Dondé et al.). Before pediatric visits, a video with a question prompt list made youth aged 11 to 17 with ADHD more likely to ask about their condition and its treatment (odds ratio 5.4) (Patient Education and Counseling, Sleath et al.).

How many psychiatrists are board certified or professionally active?

As of December 31, 2025, 42,509 general psychiatry certificates were active, by the American Board of Psychiatry and Neurology’s own count (ABPN). That is one of several counts, and they measure different things. A 2025 JAMA Network Open study by Havlik and colleagues counted 56,492 professionally active psychiatrists in 2022 (Havlik et al.), while the board has issued 76,225 psychiatry certificates since its first exam in 1935, including certificates held by doctors who have since died (ABPN).

A certificate is not a person in practice. The board’s active count leaves out psychiatrists certified before 1991 and anyone whose certificate lapsed. The Havlik figure is the Kaiser Family Foundation’s tally of professionally active psychiatrists, which the study used as its base. Government job counts for psychiatrists are in the jobs section of this page. Therapists, counselors and psychologists are counted on our mental health practice video statistics page.

How many psychiatrists hold subspecialty certificates?

Child and adolescent psychiatry is the largest psychiatric subspecialty: the American Board of Psychiatry and Neurology has awarded 14,094 certificates in it since 1959 (ABPN), and 9,597 were active at the end of 2025. The other subspecialties are far smaller. One psychiatrist can hold several of these certificates, so the rows below cannot be added together.

Active counts cover diplomates certified in 1991 or later and known not to have died.

How many new psychiatrists are certified each year?

In 2025, 2,537 candidates took the American Board of Psychiatry and Neurology’s initial psychiatry certification exam (ABPN), 2,184 passed (ABPN), a pass rate of 86% (ABPN). The child and adolescent psychiatry subspecialty exam had 608 candidates (ABPN). These are the board’s own exam records.

Certified psychiatrists keep their certificates through continuing certification. In 2025, 38,555 psychiatry diplomates took part in the board’s continuing certification pathways, most of them through its article-based option rather than an exam (ABPN).

How many psychiatrists practice in Palm Beach, Broward and Martin counties?

Florida’s physician workforce survey lists 198 psychiatrists in Palm Beach County (Florida Department of Health), 212 in Broward County (Florida Department of Health) and 14 in Martin County (Florida Department of Health), or 424 across the three (our calculation). The counts come from the Florida Department of Health’s 2026 annual report and cover physicians who renewed a Florida license between July 1, 2024 and June 30, 2026, answered the survey and provide direct patient care. The report covers 58,172 such physicians across all specialties (Florida Department of Health).

Statewide, the report’s county appendix lists 2,339 physicians with a practice specialty of psychiatry. That total includes 200 who practice out of state (Florida Department of Health) and 16 with no county recorded (Florida Department of Health), which leaves 2,123 at a Florida county address (our calculation). The three counties hold 20.0% of them (our calculation). Psychiatry makes up 4.6% of the specialty listings in the appendix, out of 51,050 (Florida Department of Health) (our calculation).

These are survey respondents, not every psychiatrist in each county. Newly licensed physicians are not surveyed, physicians may list more than one specialty, and the report does not separate child and adolescent psychiatrists or publish psychiatrists’ ages, telehealth use or retirement plans. It does report that 510 psychiatrists provide on-call services (Florida Department of Health) and that 276 plan to change their scope of practice in the next five years (Florida Department of Health). A plan is not a departure.

Is there a psychiatrist shortage?

Projections say demand will outrun supply. A 2026 Psychiatric Services study by Silvestre and colleagues projected that the national supply of psychiatrists serving adults will fall 12.3% from 2024 to 2037 (Silvestre et al.), while demand rises 43.7% (Silvestre et al.). On those figures, supply would cover 42.8% of demand in 2037 under the status quo, lower than in 2024 (Silvestre et al.).

The same authors modelled child and adolescent psychiatry in Academic Psychiatry in 2026. They put supply at 10,990 full-time equivalents in 2024 (Silvestre et al.) against status-quo demand of 14,440 (Silvestre et al.), with supply covering 64.8% of demand by 2037 (Silvestre et al.). Both studies use the federal Health Resources and Services Administration’s workforce simulation model, so these are modelled full-time equivalents, not head counts. Counts of people living in mental health shortage areas are on the mental health practice page.

Do psychiatrists accept Medicare, Medicaid and insurance?

A shrinking share of psychiatrists bill Medicare. In 2022, 33.0% of professionally active U.S. psychiatrists submitted more than 10 claims to traditional Medicare Part B (Havlik et al.), down from 44.4% in 2014, according to Havlik and colleagues in JAMA Network Open (Havlik et al.). That is a drop of 11.4 percentage points (our calculation), and the authors found the share fell in every state. Medicare covers mostly people 65 and older and people with disabilities.

State and local studies point the same way. In a 2025 Medical Care study of Georgia’s complete licensing rosters from November 2023, Tadmon and Gao found that 58.8% of psychiatrists did not accept any public insurance, Medicaid or Medicare (Tadmon and Gao). In a 2023 Psychiatric Services study, researchers at Baylor College of Medicine made simulated-patient calls to psychiatrists listed in a major insurer’s directory in three U.S. cities, seeking an appointment for a child under private insurance, Medicaid or self-pay: an initial appointment for a child was available 11% of the time (Chen et al.), and 25% of the psychiatrists were not accepting new patients (Chen et al.). The older claim that only about half of psychiatrists accept insurance is traced in the origins section of this page.

Facilities look different from private offices. In SAMHSA’s 2025 survey of mental health treatment facilities, 84.6% accepted Medicaid (SAMHSA) and 64.3% accepted Medicare (SAMHSA). Those are facility answers and say nothing about individual psychiatrists in private practice.

How many psychiatrists see patients by video?

In 2024, 85.9% of psychiatrists had provided a videoconference visit in the prior week, the highest of any specialty in the American Medical Association’s Physician Practice Benchmark Survey (AMA). 56.9% of psychiatrists provided more than a fifth of their weekly visits by video (AMA), against 9.3% of all physicians (AMA). The survey is nationally representative of physicians who provide patient care at least 20 hours a week; the psychiatry figures rest on 255 psychiatrists (AMA) out of 5,000 physicians (AMA). The AMA is a physicians’ association.

Among psychiatrists in private practices, 94.9% worked in practices that used videoconferencing with patients (AMA). Medicare claims tell the same story: in the AMA’s analysis of 2024 Medicare Part B fee-for-service claims, 31.2% of psychiatrists’ telehealth-eligible charges were billed as telehealth (AMA), compared with 3.7% of telehealth-eligible spending across all physicians (AMA).

How many mental health treatment facilities offer telehealth?

In 2025, 11,374 of the 14,153 U.S. mental health treatment facilities in the Substance Abuse and Mental Health Services Administration’s National Substance Use and Mental Health Services Survey (N-SUMHSS) offered telemedicine or telehealth therapy (SAMHSA), or 80.4% (SAMHSA). The survey counted 390 psychiatric hospitals among them (SAMHSA). The facility total rose from 2023 to 2024 mostly because thousands of facilities were added to the survey, so the series tracks survey coverage as well as growth (SAMHSA).

Florida had 619 mental health treatment facilities in the 2025 survey (SAMHSA), and 456 of them offered telehealth (SAMHSA). That is 73.7% (SAMHSA), 6.7 percentage points below the national share (our calculation).

N-SUMHSS counts facilities on SAMHSA’s list, not clinicians. Psychiatrists who offer TMS or ketamine in a private office outside that list are not in these figures, and the survey does not report how many facilities employ a psychiatrist.

How many psychiatrists bill Medicare?

CMS’s Medicare Physician & Other Practitioners file lists 19,778 providers of type Psychiatry who billed Medicare Part B fee-for-service in 2024 (CMS), down 10.1% from 21,988 in 2019 (CMS) (our calculation). The 2023 file lists 19,904 (CMS). These are claims from original Medicare only. Original Medicare covers mostly people 65 and older and people under 65 with long-term disabilities. The file leaves out Medicare Advantage plans, Medicaid, private insurance and patients who pay themselves, and it does not list providers with fewer than 11 Medicare patients. It counts people billing one payer. It is not a head count of psychiatrists.

CMS gives each provider one type a year, assigned from the claims. A search of the 2019 and 2024 files for any type containing “sychiatr” returns exactly three: Psychiatry, Geriatric Psychiatry and Neuropsychiatry. This page reports them separately and merges none into another. Nurse practitioners, including those who work in psychiatry, fall under CMS’s separate Nurse Practitioner type and are not in these counts. CMS lists 164 providers of type Geriatric Psychiatry in 2024 (CMS), down 15.9% from 195 in 2019 (CMS) (our calculation). For context, it lists 202 of type Neuropsychiatry in 2024 (CMS) against 124 in 2019 (CMS), and 280 of type Addiction Medicine in 2024 (CMS) against 230 in 2019 (CMS).

Florida’s Psychiatry count rose 0.4% from 2019 to 2024 while the national count fell, and Florida holds 5.5% of the U.S. total in 2024 (our calculation). The file cannot say why the national count fell. A provider drops out if patients move to Medicare Advantage, if the provider falls under the 11-patient floor, or if the provider stops billing Medicare, and the file does not separate those cases.

How many psychiatrists bill Medicare in Palm Beach, Broward and Martin counties?

97 providers of type Psychiatry with a Palm Beach County practice address billed Medicare Part B fee-for-service in 2024, 105 in Broward County and 10 in Martin County, by our match of CMS’s by Provider file to the Census Bureau’s ZIP-to-county relationship file. The three counties hold 19.4% of Florida’s 1,093 providers of that type (our calculation). This is the same original-Medicare count as above. It says who billed original Medicare, not how many psychiatrists practice in each county.

A ZIP code split across counties goes to the county holding most of its land, so a practice in a border ZIP can count in the neighboring county. The counts and payment sums are in this page’s aggregate CSV, which holds no provider names or NPIs.

How much does Medicare pay psychiatrists?

Medicare paid providers of type Psychiatry $655.7 million (655,694,331) for Part B fee-for-service services in 2024, by our sum of CMS’s by Provider file. That is 19.6% less than the $815.2 million (815,203,351) it paid them in 2019, before inflation (our calculation). Providers of the separate type Geriatric Psychiatry received $8,482,094 in 2024 (our calculation). A payment total is what Medicare paid for services. It is not a physician’s income, and it leaves out what Medicare Advantage plans, Medicaid, insurers and patients paid.

A median provider is the one in the middle of the list: half received more and half received less. The median provider of type Psychiatry received $15,608 from Medicare Part B fee-for-service in 2024, down 19.0% from $19,263 in 2019, before inflation, and treated 46 Medicare patients, against 70 in 2019 (our calculation). The median Florida provider of that type received $23,814 in 2024 (our calculation).

Summed across providers, the beneficiary counts of providers of type Psychiatry come to 1.54 million (1,542,424) in 2024, down 39.0% from 2.53 million (2,528,151) in 2019 (our calculation). A patient seen by two psychiatrists counts on both rows, so this is not a count of people. Like the provider count, it shrinks when patients move to Medicare Advantage.

Who are psychiatrists’ Medicare patients?

Medicare Part B fee-for-service patients of providers of type Psychiatry averaged 65.5 years of age in 2024, against 62.2 in 2019 (our calculation, weighting each provider’s published average by that provider’s patients). 59.7% of providers of that type had Medicare patients whose average age was under 65 in 2024 (our calculation). People under 65 qualify for Medicare through a long-term disability or certain illnesses, and the file does not record which applies to each patient.

CMS flags chronic conditions from each patient’s Medicare claims. Weighted by each provider’s patients, those flags put 65.6% of the Medicare patients of providers of type Psychiatry in the depressive disorders group in 2024 and 39.1% in the schizophrenia and other psychotic disorders group, on the rows that publish the figures (our calculation). A patient can be in both groups, and a patient seen by two psychiatrists counts twice. CMS withholds a percentage where it could identify a small number of people, so those rows are left out.

How many Medicare patients get psychiatric evaluations, psychotherapy add-ons, TMS, ECT or esketamine?

260,229 Medicare beneficiaries had a psychiatric diagnostic evaluation with medical services on an office-setting line in 2024, and 224,942 on a facility-setting line such as a hospital (CPT 90792) (CMS). The office figure is down 11.3% from 293,443 in 2019 (CMS) and the facility figure up 0.4% from 224,120 (CMS) (our calculation). These counts come from CMS’s by Geography and Service file and cover every specialty, not psychiatrists alone. They count patients, not services, and a patient billed in two settings or under two codes counts on each row. Original Medicare only: no Medicare Advantage, Medicaid or private insurance.

The 99214 row covers every specialty and is there for scale; the psychiatry figures for it are below. The 2019 file has no national row for the esketamine codes. The file has no diagnosis field and does not mark which visits were by video, so it cannot show why a count moved or how much of it was telehealth.

Narrowing to providers of type Psychiatry, the published lines of CMS’s 2024 provider-and-service file sum to 458,784 beneficiary counts for established-patient visits with a moderate level of decision making (CPT 99214), 90.5% of them on office-setting lines; 188,518 for the 30-minute psychotherapy add-on (CPT 90833), 87.4% on office-setting lines; and 181,821 for diagnostic evaluations with medical services (CPT 90792), only 45.9% on office-setting lines (our calculation). Facility-setting lines held 20.6% of the beneficiary counts on Psychiatry lines for 12 codes (CPT 90791, 90792, 90833, 90836, 90838, 99214 and 90867 to 90870, and HCPCS G2082 and G2083) in 2024, against 25.6% in 2019 (our calculation). These are sums across lines, so a patient billed by two psychiatrists counts on both, and lines under 11 patients are suppressed.

Providers of type Psychiatry hold 94.0% of the beneficiary counts on published lines for electroconvulsive therapy (CPT 90870), 94.3% for TMS treatment sessions (CPT 90867 and 90868) and 70.0% for the esketamine visit codes (HCPCS G2082 and G2083) in 2024 (our calculation). The same Psychiatry lines sum to 30,277 beneficiary counts for audio-only telephone visits (CPT 99441-99443) in 2024 (our calculation).

How many psychiatrists work in the United States?

The Bureau of Labor Statistics estimated 27,980 wage and salary psychiatrist jobs (SOC 29-1223) in the U.S. in May 2025, in its Occupational Employment and Wage Statistics (OEWS) survey of employers (BLS). Psychiatrists have their own BLS occupation code, so the figures in this section are specific to them unless labelled otherwise. OEWS counts jobs that employers report and leaves out psychiatrists who own their practices and take profits rather than a wage.

BLS’s Employment Projections, which also count the self-employed, put psychiatrist jobs at 30,000 in 2025 (BLS), and the self-employed share at 3.2% (BLS). The Occupational Outlook Handbook groups psychiatrists with all physicians and surgeons: its lead job count, about 862,800 U.S. jobs in 2025 (BLS), covers the whole group, and psychiatrists appear only as one line in its employment, wage and projections tables. Those psychiatrist lines are the figures we use here. Both sources count jobs, not licensed or board-certified psychiatrists; board certificates are covered in the practice section. Therapists, counselors and psychologists are counted on our mental health practice video statistics page.

How much do psychiatrists earn?

The median annual wage of psychiatrists (SOC 29-1223) in the United States was $281,870 in May 2025, per BLS OEWS (BLS). The mean annual wage was $269,940, below the median (BLS). No psychiatrist wage figure in this section carried a BLS top-coding footnote, so these are published estimates, not floors. They cover wages and salaries only, not practice owners’ profits, and OEWS is not built for comparing one year with the next.

Where do psychiatrists work?

Offices of physicians employed 8,680 U.S. wage and salary psychiatrists in May 2025, per BLS OEWS (BLS): 31.0% of the national count (our calculation). The table below lists other settings with BLS estimates for the occupation. BLS did not release a May 2025 psychiatrist employment estimate for psychiatric and substance abuse hospitals.

Psychiatrists working in offices of physicians had a median annual wage of $299,670 in May 2025 (BLS). OEWS does not say why pay differs by setting. Offices of psychiatrists sit inside offices of physicians, and their own industry figures are in the next section.

How many psychiatrists work in Florida and in the Miami and Port St. Lucie areas, and what do they earn?

BLS OEWS estimated 1,930 wage and salary psychiatrist jobs in Florida in May 2025 (BLS). Their median annual wage was $316,200 (BLS), 12.2% above the national median (our calculation), and their mean annual wage was $328,060 (BLS).

The Miami-Fort Lauderdale-West Palm Beach metro area, which covers Miami-Dade, Broward and Palm Beach counties, had 720 wage and salary psychiatrist jobs in May 2025 (BLS), 37.3% of Florida’s count (our calculation). The median annual wage there was $403,430 (BLS), 43.1% above the national median (our calculation), and the mean was $378,670 (BLS).

OEWS publishes no estimates for counties, and the BLS data service holds no May 2025 series for the metro area’s divisions, including West Palm Beach. It holds no psychiatrist series at all for the Port St. Lucie metro area, which includes Martin County, even though that area’s all-occupations estimates exist. OEWS therefore gives no psychiatrist count and no psychiatrist wage for Palm Beach, Broward or Martin counties on their own.

How fast are psychiatrist jobs expected to grow?

BLS projects psychiatrist jobs to grow 7.2% from 2025 to 2035, per its Employment Projections (BLS). The Occupational Outlook Handbook puts that at 32,100 U.S. jobs in 2035 (BLS), up from 30,000 in 2025, a gain of 2,100 (BLS). For physicians and surgeons as a whole, BLS projects growth of 4 percent over the same decade, “about as fast as the average for all occupations” (BLS).

BLS expects about 0.9 thousand psychiatrist openings a year from 2025 to 2035, from growth and from replacing workers who leave the occupation (BLS). The Handbook says “growing demand for psychiatric care and improved access to mental health services will support job growth for psychiatrists.” These projections count all psychiatrist jobs, including the self-employed.

How many psychiatrist offices are there in the U.S.?

BLS’s Quarterly Census of Employment and Wages (QCEW), which counts employers covered by unemployment insurance, averaged 16,840 private offices of psychiatrists in the U.S. in 2025 (BLS). The industry is offices of physicians, mental health specialists (NAICS 621112): offices of psychiatrists and other physicians who specialize in mental health, so the figures in this section are specific to psychiatrist practices. QCEW counts worksites, so a group practice with several locations counts each one, and it leaves out practices with no employees.

The count grew 63.6% from 10,291 private offices in 2015 (BLS) (our calculation). In 2025 these offices averaged 87,333 employees (BLS), about 5.2 per office (our calculation), and average annual pay across all their jobs was $80,955 (BLS). That average covers front-desk staff, nurses, therapists and employed physicians alike, so it is not a psychiatrist’s pay.

The Census Bureau’s County Business Patterns counted 13,449 U.S. offices of psychiatrists with paid employees in 2023, the newest year available when we checked (Census). 10,739 of them had fewer than five employees (Census): 79.8% (our calculation). Census and BLS define establishments differently and these counts cover different years, so the two totals should not be compared directly.

The 2022 Economic Census, the Census Bureau’s full count of businesses every five years, counted 12,412 U.S. employer offices of psychiatrists (Census), with receipts of $10.2 billion ($10,222,838 thousand) in 2022, not adjusted for inflation (Census).

How many psychiatrist practices have no paid employees?

Census’s Nonemployer Statistics counted 55,560 U.S. psychiatrist-office businesses with no paid employees in 2024 (Census), with receipts of $4.69 billion ($4,688,669 thousand) (Census). Most are sole proprietors filing business tax returns. A nonemployer can also be a psychiatrist’s side, locum or consulting income alongside a salaried job, so this is a count of businesses on paper, not of full-time solo practices.

For 2023, the year of the newest County Business Patterns, Nonemployer Statistics counted 53,044 such businesses (Census): about 3.9 for every psychiatrist office with employees (our calculation).

How many psychiatrist offices are there in Florida and in Palm Beach, Broward and Martin counties?

Florida averaged 1,830 private offices of psychiatrists (NAICS 621112) in 2025, per BLS’s QCEW (BLS), 10.9% of the U.S. total (our calculation). They averaged 9,073 employees (BLS), and average annual pay across all their jobs was $72,052 (BLS).

Average pay covers all staff in these offices, not only psychiatrists. Martin County’s counts are small, so a single practice opening or closing moves them noticeably. The Census counts below come from different years and different kinds of business, so we do not add the two columns.

How many psychiatrist offices earn money from telemedicine?

9,787 U.S. employer offices of psychiatrists (NAICS 621112) reported some revenue from telemedicine services in 2022, per the 2022 Economic Census (Census): 78.9% of the 12,412 such offices (our calculation). The table counts offices with any telemedicine revenue. It does not say how much of their revenue came from it or what share of visits were by video, and it leaves out practices with no employees.

How much do physician offices spend on advertising?

U.S. offices of physicians of all specialties (NAICS 6211) spent $1,815,721 thousand, about $1.8 billion, on advertising and promotion in 2024, per the Census Bureau’s Annual Integrated Economic Survey (Census). That was 0.28% of their total 2024 operating expenses (our calculation). It is a sample estimate shared by every physician specialty: Census does not publish advertising spending for offices of psychiatrists on their own.

How many Americans get mental health treatment, and how many see a psychiatrist?

In 2024, 22.9% of U.S. adults (60.1 million) received some form of mental health treatment in the past year, according to SAMHSA’s National Survey on Drug Use and Health (NSDUH) (SAMHSA). NSDUH is a household survey of the civilian, noninstitutionalized population aged 12 or older; the 2024 round had 70,241 completed interviews, 56,228 of them with adults (SAMHSA), and an overall weighted response rate of 11.3% (SAMHSA). Answers are self-reported.

Prescription medication was the most common form of treatment: 16.7% of U.S. adults (43.8 million) took medication to help with their mental health in 2024 (SAMHSA). 12.8% of adults (33.4 million) received mental health treatment by telehealth, meaning by phone or video (SAMHSA).

NSDUH does not count psychiatrists on their own. Its closest category is treatment in “the office of a therapist, psychologist, psychiatrist, or mental health professional”, which 9.9% of U.S. adults reported in 2024 (SAMHSA). For psychiatrist-only counts, see the Medicare and workforce sections of this page; therapy and counseling figures are on our mental health practice video statistics page.

Among U.S. adolescents aged 12 to 17, 28.5% (7.4 million) received mental health treatment in 2024 (SAMHSA). 13.1% (3.4 million) received it by telehealth and 21.3% (5.5 million) in an outpatient setting (SAMHSA). 13.5% were treated in the office of a therapist, psychologist, psychiatrist or mental health professional, and 12.9% took prescription medication for their mental health (SAMHSA).

Federal surveys ask about medication in different ways, so their answers differ.

The NHIS figure comes from the same 2024 survey in which 14.0% of adults received counseling or therapy from a mental health professional (NCHS). The antidepressant figure is the newest in an NCHS Data Brief and predates the pandemic: use was 17.7% among women and 8.4% among men (NCHS).

How common is depression in the U.S.?

In 2024, 8.2% of U.S. adults aged 18 or older (21.4 million) had a major depressive episode in the past year, according to SAMHSA’s NSDUH (SAMHSA). NSDUH counts a major depressive episode from survey questions based on DSM-5 symptoms lasting 2 weeks or longer; it is not a clinical diagnosis. The adult rate was 8.5% in 2021, 8.8% in 2022, 8.5% in 2023 and 8.2% in 2024, which SAMHSA labels “No Change” (SAMHSA).

Younger people moved the other way. Among young adults aged 18 to 25 the rate fell from 19.3% (6.4 million) in 2021 to 15.9% (5.5 million) in 2024 (SAMHSA). In 2024, 15.4% of U.S. adolescents aged 12 to 17 (3.8 million) had a major depressive episode in the past year (SAMHSA), down from 20.8% (5.2 million) in 2021 (SAMHSA).

The National Center for Health Statistics measures depression differently, with the PHQ-9 questionnaire about the past 2 weeks in its NHANES exam survey. During August 2021-August 2023, 13.1% of U.S. adolescents and adults aged 12 and older had depression on that measure (NCHS). It was highest among adolescents aged 12 to 19, at 19.2%, and lowest among adults aged 60 and older, at 8.7% (NCHS). The NHANES rate rose from 8.2% in 2013-2014 to 13.1% in August 2021-August 2023 (NCHS).

The NSDUH and NHANES figures do not contradict each other: one asks about an episode at any point in the past year, the other screens current symptoms with a cutoff score, and the age groups and years differ.

How many people with depression get treatment?

Of the 21.4 million U.S. adults with a past-year major depressive episode in 2024, 64.4% (13.8 million) received mental health treatment in the past year, according to NSDUH (SAMHSA). 50.9% of adults with an episode (10.9 million) took prescription medication for their mental health (SAMHSA), so about 79.0% of those treated took medication (our calculation). 42.4% (9.1 million) received treatment by telehealth (SAMHSA), and 36.9% were treated in the office of a therapist, psychologist, psychiatrist or mental health professional (SAMHSA).

Of the 7.6 million adults with an episode who received no mental health treatment in 2024, 33.5% (2.5 million) perceived an unmet need for it, meaning they sought treatment or thought they should get it (SAMHSA).

Among U.S. adolescents with a past-year major depressive episode in 2024, 60.6% (2.3 million) received mental health treatment (SAMHSA). About 40% (1.5 million) did not, and 33.2% received treatment by telehealth (SAMHSA).

NCHS’s exam survey gives a lower figure on a narrower question. Among people aged 12 and older with depression on the PHQ-9 in August 2021-August 2023, 39.3% received counseling or therapy from a mental health professional in the previous 12 months (NCHS). The question names psychiatrists, psychologists, psychiatric nurses and clinical social workers, and it leaves out medication alone.

How do Florida’s depression and treatment rates compare with the U.S.?

In 2024, 17.55% of Florida adults received mental health treatment in the past year, against 22.90% of U.S. adults, according to SAMHSA’s NSDUH state estimates (SAMHSA). That is a gap of 5.35 percentage points (our calculation), and about 3.3 million Florida adults (3,253 thousand) (SAMHSA). Among Florida adolescents aged 12 to 17, 24.53% received mental health treatment in 2024 (SAMHSA).

On the same model, 7.64% of Florida adults had a past-year major depressive episode in an average year of 2023-2024, against 8.33% of U.S. adults (SAMHSA). That is about 1.4 million Florida adults a year (1,393 thousand) (SAMHSA). Among Florida adolescents, 16.33% had a past-year major depressive episode in an average year of 2023-2024 (SAMHSA).

These state figures are model-based small area estimates from pooled 2023 and 2024 survey data (treatment uses 2024 only), not direct counts, so the U.S. depression figure here differs slightly from the single-year national rate above. NSDUH does not publish county estimates for Palm Beach, Broward or Martin counties in these tables.

How common is ADHD in children and adults, and how is it treated?

An estimated 7 million (11.7%) U.S. children aged 3-17 had a current ADHD diagnosis in 2024, according to CDC, citing HRSA’s National Survey of Children’s Health, a survey of parents (CDC). In 2022, about 30% of children with ADHD received neither medication nor behavior treatment, compared with 23% in 2016 (CDC). About 32% received both, and the number of children receiving behavior treatment rose from 2.5 million in 2016 to 2.8 million in 2022 (CDC).

For adults, a CDC survey of 7,046 adults in October-November 2023 found that an estimated 15.5 million U.S. adults (6.0%) had a current ADHD diagnosis, by self-report (MMWR). 55.9% of them were diagnosed at age 18 or older (MMWR). 36.5% were receiving no ADHD treatment, while 35.2% were receiving both medication and counseling or behavioral treatment (MMWR). 50.4% were prescribed ADHD medication in the previous 12 months and 33.4% took a prescription stimulant (MMWR). Of those taking a stimulant, 71.5% had difficulty getting the prescription filled because the medication was not available (MMWR).

Telehealth is a large part of adult ADHD care in this survey. In October-November 2023, 46.0% of adults with ADHD had ever received telehealth services for it; 8.9% were diagnosed by telehealth only and 9.5% through a mix of telehealth and in-person visits (MMWR). Since March 2020, 30.5% had used telehealth to get a prescription for ADHD medication and 30.8% to receive counseling or therapy for ADHD (MMWR). The DEA rules on prescribing stimulants by telemedicine are covered in the rules section of this page.

How many people die by suicide in the U.S. and in Florida?

48,824 people died by suicide in the United States in 2024, an age-adjusted rate of 13.7 per 100,000, according to final death certificate data from the National Center for Health Statistics (NCHS). That was 492 fewer deaths than in 2023 (our calculation), when 49,316 people died by suicide at a rate of 14.1 (NCHS). The age-adjusted rate rose from 13.0 per 100,000 in 2014 to 14.0 in 2017, with no significant change between 2017 and 2024 (NCHS). In 2024 the rate was 22.3 per 100,000 for males and 5.6 for females (NCHS).

In Florida, NCHS counted 3,633 suicide deaths among residents in 2024, an age-adjusted rate of 13.9 per 100,000 (NCHS). The Florida Department of Health counted 3,591 for the same year, also at 13.9 (Florida DOH), a difference of 42 deaths (our calculation). For 2025 the state counted 3,564 suicide deaths among Florida residents, an age-adjusted rate of 13.7 (Florida DOH).

The national and state death files are counted separately and do not match exactly. Together, Palm Beach, Broward and Martin counties recorded 470 suicide deaths in 2025, 13.2% of Florida’s total (our calculation). County rates built on a few dozen deaths, as in Martin County, move a lot from year to year. The 2025 state figures were read on November 9, 2026 and may still be revised.

What do telehealth and drug companies disclose about psychiatry?

LifeStance Health, the largest listed outpatient mental health group, counted 8,040 employed psychiatrists, advanced practice nurses, psychologists and therapists at the end of 2025, and does not split that total by profession (LifeStance fiscal 2025 10-K). Its clinicians treated more than 1.0 million patients through approximately 9.0 million visits in 2025, in person and by video (10-K). Every figure in this section is a company’s own number from its annual report (Form 10-K) on SEC EDGAR, and every one of these companies sells into the market it describes: they are sellers, not neutral counters. Therapy platforms (Talkspace, BetterHelp) have a fuller section on our mental health practice video statistics page; the figures repeated here use the same values.

The table mixes units on purpose: providers, facilities, admissions and dollars are each the company’s own measure, and the reports do not use one definition of a clinician or a facility. LifeStance and Talkspace give no separate count of psychiatrists. Acadia says psychiatrists and other physicians in its facilities are generally not its employees and work as independent contractors or medical staff members (Acadia fiscal 2025 10-K). UHS’s admissions and its revenue share cover its U.K. and Puerto Rico facilities as well as the U.S. ones. Johnson & Johnson’s SPRAVATO sales rose 57.4% from 2024 (J&J fiscal 2025 10-K), and the company says the growth was driven by continued increased physician and patient demand (J&J fiscal 2025 10-K). AUVELITY’s U.S. net sales grew 74.0% from 2024 to 2025 and LYBALVI’s grew 23.8% (our calculation from the filings above).

What do telehealth companies say about video visits and controlled substances?

Talkspace says its psychiatry packages typically start with an initial video consultation, with follow-up video appointments as needed (Talkspace fiscal 2025 10-K); it offers psychiatric treatment and medication management to adults only (18+) and text, audio and video-based therapy (10-K). It also says that, in accordance with the DEA Ryan Haight Act, its providers do not prescribe controlled substances (10-K). LifeStance’s fiscal 2025 report says the DEA’s telehealth flexibility for prescribing certain controlled substances without an in-person evaluation had been set to end December 31, 2025, and that the DEA published a notice on November 10, 2025 of its intent to extend it a fourth time (LifeStance 10-K); it warns that some states impose strict standards on using telehealth to prescribe controlled substances commonly used for mental health disorders (10-K). The rules themselves are covered in our section on DEA, FDA, FTC, HIPAA and Florida rules.

LifeStance says its payor relationships have historically let it secure rate parity between in-person and virtual visits (10-K), and that in 2023 it began closing certain centers because its business had shifted to more virtual visits (10-K). The report does not give a share of visits held by video. Teladoc lists the continued expansion of psychiatric services through Uplift among its growth initiatives (Teladoc fiscal 2025 10-K); it bought Uplift Health Technologies on April 30, 2025 for $29.6 million in cash (10-K). Amwell went the other way: in January 2025 it sold its telepsychiatry business serving hospitals and correctional programs for an upfront $20.7 million plus an earn-out (Amwell fiscal 2025 10-K). Hims & Hers lists mental health among the conditions its platform treats (Hims & Hers fiscal 2025 10-K) and says it may in the future offer prescription drugs regulated as controlled substances (10-K).

What do psychiatric drug makers say about sales forces and advertising?

Neurocrine says its specialized U.S. sales force of approximately 600 professionals focuses on neurology, psychiatry, long-term care and rare diseases (Neurocrine fiscal 2025 10-K). Alkermes’s U.S. sales force for ARISTADA and LYBALVI, its schizophrenia and bipolar I drugs, was approximately 435 people at the end of 2025 (Alkermes fiscal 2025 10-K). Supernus runs one sales force aimed at psychiatrists, pediatricians, primary care physicians and advanced practice providers in ADHD (Supernus fiscal 2025 10-K) and a third aimed at psychiatrists, obstetrician-gynecologists and other health professionals in postpartum depression (10-K).

Axsome’s selling, general and administrative expenses rose to $570.6 million in 2025, which it attributes mainly to AUVELITY commercial activities, including a national direct-to-consumer advertising campaign and a larger sales force (Axsome fiscal 2025 10-K). The same report says that in early September 2025, after a presidential memorandum on prescription drug advertising, the FDA issued more than 100 enforcement letters alleging that certain promotional communications and direct-to-consumer ads were false and misleading (10-K). Neurocrine lists a federal plan to increase enforcement on direct-to-consumer pharmaceutical advertising among government actions that may affect its business (10-K). Neuronetics, which sells TMS systems for depression, says its practice development managers teach office staff to use patient educational tools such as presentations, videos and starter kits (Neuronetics fiscal 2025 10-K), and it names a NeuroStar YouTube account among the channels it uses to share company information (10-K).

How often do annual reports mention psychiatrists and video?

29 Form 10-K annual reports filed in 2025 contained the word “psychiatrist” or “psychiatrists”, by our count with SEC EDGAR full-text search on November 9, 2026 (our calculation). From 2001 to 2025, 680 filings did, from 191 distinct registrants; the yearly count peaked at 44 in 2009 and was 25 in 2001. 26 more were filed in 2026 through November 9. 21 of the 2025 filings came from drug, device, lab or health-services filers with the word in the main report rather than an exhibit. We counted distinct 10-K filings (amendments excluded) by filing year, so 2025 mostly means fiscal 2024 reports; full-text search does not stem, so “psychiatric” and “psychiatry” are not counted. Per-year counts with filer names and query links are in edgar-psychiatrist-10k-counts.csv.

10 of the 29 filings from 2025 also contained “video” or “videos”, and 113 of the 680 did from 2001 to 2025, or 16.6%. That count peaked at 13 in 2024, and 8 of the 26 filings from 2026 so far contain both. 9 of the 29 filings from 2025 also contained “telehealth”; from 2001 to 2025, 58 filings paired a psychiatrist word with “telehealth”, the first in filing year 2011.

We read the passages around the word in all 54 filings from 2022 through November 9, 2026 that contain a psychiatrist word and a video word, and gave each filing one category. 17 use “video” for telehealth or video visits, most of them Talkspace and Teladoc reports. 7 use it for marketing or patient-facing video: five Neuronetics reports on patient education videos for TMS practices, an ADHD drug launch plan and a mental health app. 4 describe training or education video for clinicians or staff, and 4 a clinical study or treatment (a prescription video game for ADHD, and video vignettes scored by trial raters). The other 22 use the word for unrelated things such as children’s video-on-demand, video games sold in stores, employee benefits, investor presentations or a hearing held by video conference. 0 of the 54 contain the phrases “educational video”, “training video”, “marketing video”, “promotional video” or “instructional video”; 6 contain “video consultation” (MediXall Group and Talkspace). 10 filings from 2022 on pair a psychiatrist word with “YouTube”, from Neuronetics, which lists its own YouTube account, a children’s media company and MediXall, and 1 pairs it with “TikTok”: the children’s media company naming TikTok as a distribution platform. The categories and passages are in edgar-psychiatrist-10k-contexts.csv.

Of the 13 named companies’ newest annual reports, 5 use “video” or “videos” (Amwell, Hims & Hers, Neuronetics, Talkspace and Teladoc) and 6 use “psychiatrist” or “psychiatrists” (Acadia Healthcare, LifeStance, Neuronetics, Supernus, Talkspace and Teladoc). 3 use none of the words psychiatrist, psychiatric or psychiatry: Alkermes and Johnson & Johnson, which both sell psychiatric drugs, and Hims & Hers (our calculation).

What rules govern psychiatry telehealth, prescribing and advertising?

DEA and HHS’s fourth temporary extension lets DEA-registered practitioners keep prescribing controlled medications by telemedicine without a prior in-person evaluation through December 31, 2026 (Federal Register). As we read the Federal Register on November 9, 2026, no further extension and no final telemedicine rule had been published. Each rule below is dated and quoted from its own text: federal prescribing law, Florida statutes and Board of Medicine rules, HIPAA and 42 CFR Part 2, FTC and FDA advertising rules, Medicare telehealth payment and YouTube’s policies. Rules for therapists, counselors and therapy platforms are on our mental health practice video statistics page.

What does the Ryan Haight Act require before a controlled substance is prescribed online?

The Ryan Haight Online Pharmacy Consumer Protection Act, Public Law 110-425, was approved October 15, 2008 (GovInfo). It defines a valid prescription for a controlled substance dispensed by means of the internet as one issued by a practitioner who has conducted “at least 1 in-person medical evaluation of the patient”, or by a covering practitioner (Public Law 110-425). A covering practitioner acts for a practitioner who has evaluated the patient in person or through telemedicine within the previous 24 months and is temporarily unavailable (Public Law 110-425). DEA describes the Act as setting out seven excepted categories of telemedicine in which a practitioner may prescribe without that in-person evaluation (Federal Register).

How have DEA and HHS extended the COVID-era telemedicine flexibilities?

The flexibilities let all DEA-registered practitioners prescribe Schedule II-V controlled medications by audio-video telemedicine without an in-person evaluation (Federal Register). DEA and HHS have carried them forward by temporary rule, each with its own end date.

DEA’s proposed rule of January 17, 2025 would set up special registrations for telemedicine. One type, the Advanced Telemedicine Prescribing Registration, would let specialized clinicians prescribe Schedule II-V controlled substances by telemedicine, and the proposal names psychiatrists as an example (Federal Register). It would also require a clinician’s Schedule II prescriptions under the special registration to be less than 50 percent of all their Schedule II prescriptions in a calendar month (Federal Register). DEA received over 6,475 comments on the proposal (Federal Register). The Department of Justice’s 2026 Regulatory Plan lists the final action for 11/00/26, the agenda’s notation for November of that year (Federal Register). It is a proposal, not law, and no final rule had been published by November 9, 2026.

A separate final rule lets a practitioner prescribe an initial six-month supply of Schedule III-V medicines for opioid use disorder, split across several prescriptions, by audio-only telemedicine after checking the state prescription drug monitoring program (Federal Register). Its effective date, and that of a companion rule for Veterans Affairs patients, was delayed to December 31, 2025 (Federal Register).

What do Florida’s telehealth, prescribing and Baker Act statutes say about psychiatric care?

Florida’s telehealth statute, s. 456.47, defines telehealth as the use of “synchronous or asynchronous” telecommunications technology to provide health care services, and the term does not include e-mail messages or facsimile transmissions (Florida Statutes 456.47). It bars a telehealth provider from prescribing a Schedule II controlled substance by telehealth unless the drug is prescribed for the treatment of a psychiatric disorder, inpatient hospital treatment, a hospice patient or a nursing home resident (Florida Statutes 456.47). The section was created by chapter 2019-137, Laws of Florida, and amended through chapter 2023-132 (Florida Statutes 456.47). Florida’s statute on prescribing controlled substances for chronic nonmalignant pain, s. 456.44, says managing pain in patients with a history of substance abuse or a “comorbid psychiatric disorder” requires consultation with or referral to an addiction medicine specialist or a psychiatrist (Florida Statutes 456.44).

Under the Baker Act, s. 394.463, an involuntary examination lasts up to 72 hours from a person’s arrival at the receiving facility (Florida Statutes 394.463). For a minor, the examination must begin within 12 hours of arrival (Florida Statutes 394.463). When a psychiatrist initiated the examination, a psychiatric nurse may not approve release without that psychiatrist’s approval, and the statute says the release may be approved through telehealth (Florida Statutes 394.463).

What does Florida’s Board of Medicine rule say about a psychiatrist’s advertising?

The latest adopted version of rule 64B8-11.001 (Advertising) took effect 3/19/2026 (Florida Administrative Code). It deems a physician’s ad false, deceptive or misleading if it creates false or “unjustified expectations of beneficial assistance” (Florida Administrative Code 64B8-11.001), or if it conveys qualifications or skills “superior to other physicians” beyond a simple listing of earned achievements recognized by the Board (Florida Administrative Code 64B8-11.001). A physician who advertises on electronic media must keep an exact copy of the audio or video ad for at least six months from the date it airs (Florida Administrative Code 64B8-11.001). The text of the rule, as we read it on November 9, 2026, contains neither the word “testimonial” nor the word “guarantee” and does not mention psychiatry. Florida law allows an administrative fine of up to $10,000 for each count or separate offense (Florida Statutes 456.072).

How do HIPAA and 42 CFR Part 2 treat psychiatric records and marketing?

HIPAA defines psychotherapy notes as a mental health professional’s notes on the contents of a counseling session, kept apart from the rest of the medical record, and excludes “medication prescription and monitoring”, session start and stop times, test results and summaries of diagnosis, treatment plan, symptoms, prognosis and progress (eCFR, 45 CFR 164.501). A covered entity must obtain the patient’s authorization for almost any use or disclosure of psychotherapy notes (eCFR, 45 CFR 164.508). A patient’s right to inspect and copy their records excludes “Psychotherapy notes” and material compiled for legal proceedings (eCFR, 45 CFR 164.524). A covered entity such as a psychiatric practice “must obtain an authorization” before using or disclosing protected health information for marketing, except for face-to-face communications and promotional gifts of nominal value (eCFR, 45 CFR 164.508).

HHS’s final rule revising 42 CFR Part 2, which governs the confidentiality of substance use disorder treatment records, took effect April 16, 2024 (Federal Register), and programs subject to it had to comply by February 16, 2026 (Federal Register).

What do FTC and FDA rules say about endorsements and drug ads?

The FTC’s revised Endorsement Guides, 16 CFR Part 255, took effect July 26, 2023 (Federal Register). If an advertiser does not have substantiation that an endorser’s experience is representative of what consumers will generally achieve, the ad should disclose the generally expected performance in the depicted circumstances (eCFR, 16 CFR 255.2). When an endorsement is made through both pictures and sound, as in a video, the disclosure should appear in both the visual and audible portions (eCFR, 16 CFR 255.0). In the Guides’ example of a doctor who endorses a drug relying only on letters from satisfied consumers or a rodent study, “both the advertiser and the doctor would be liable” (eCFR, 16 CFR 255.3).

FDA’s rule at 21 CFR 202.1 requires the major statement in a TV-format prescription drug ad to be presented in audio and text at the same time, which the rule calls “dual modality” (eCFR, 21 CFR 202.1). The final rule adding that standard took effect on May 20, 2024 (Federal Register). An ad does not present a true statement if it fails to present a “fair balance” between information on side effects and contraindications and information on effectiveness (eCFR, 21 CFR 202.1). HHS’s penalty table sets the maximum penalty for a first false or misleading direct-to-consumer drug ad in any 3-year period at $377,701 (eCFR, 45 CFR 102.3).

What boxed warnings has FDA required on antidepressants and stimulants?

FDA’s May 2007 consumer update says that in 2005 FDA asked manufacturers to add a black box warning to the labeling of all antidepressants about a risk of suicidal thinking and behavior in children and adolescents (FDA, archived copy). On May 2, 2007 FDA proposed extending the warnings to young adults ages 18 to 24 during initial treatment, generally the first one to two months (FDA, archived copy).

FDA’s Drug Safety Communication dated 05-11-2023 required updates to the Boxed Warning on all prescription stimulants, so that it describes the risks of misuse, abuse, addiction and overdose consistently across the class (FDA). In the same communication FDA said dispensing of Schedule II stimulants almost doubled in ten years, from approximately 12.5 million prescriptions in the first quarter of 2011 to 20 million in the first quarter of 2022, in its own analysis of IQVIA data (FDA).

What are Medicare’s telehealth rules for mental health visits?

CMS’s CY 2027 Physician Fee Schedule final rule was published on November 9, 2026 and takes effect January 1, 2027 (Federal Register). It says section 6209(d) of the Consolidated Appropriations Act, 2026 delays Medicare’s in-person visit requirement for mental health services furnished through telehealth to January 1, 2028 (Federal Register), and section 6209(e) extends audio-only Medicare telehealth to January 1, 2028 (Federal Register). The wider flexibilities, which remove geographic restrictions and expand the lists of originating sites and practitioners, run to December 31, 2027 (Federal Register).

CMS’s regulation lists the patient’s home as an originating site for mental health telehealth and conditions payment on an in-person service by the practitioner within 6 months before the initial telehealth service, the requirement the statute has delayed (eCFR, 42 CFR 410.78). Audio-only service to a patient at home is allowed when the patient cannot use or does not consent to video, and claims carry CPT modifier 93 (eCFR, 42 CFR 410.78).

What do YouTube’s policies say about suicide, self-harm and medical content?

YouTube’s suicide, self-harm and eating disorders policy, as read on November 9, 2026, says YouTube does not allow content that “promotes suicide, self-harm, or eating disorders”, is intended to shock or disgust, or poses a considerable risk to viewers, with exceptions for educational, documentary, scientific or artistic context (YouTube Help). The page lists the Suicide & Crisis Lifeline, 988, as its United States resource (YouTube Help). YouTube’s medical misinformation policy bars content that poses a serious risk of egregious harm by contradicting “local health authority (LHA) guidance” about specific health conditions and substances (YouTube Help). To be a source in YouTube’s health features, a licensed professional’s channel needs more than 1,500 valid public watch hours in the last 12 months, or 1.5 million valid public Shorts views in the past 90 days (YouTube Help).

This section summarizes published laws, rules and platform policies as worded on the dates given. It is not legal or medical advice.

What do the popular psychiatry numbers really say?

Five numbers travel through psychiatry practice pages, advocacy sites and news stories: “1 in 5 adults” have a mental illness, half of mental illness begins by 14, “90%” of people who die by suicide have a mental illness, only about half of psychiatrists accept insurance, and video lifts conversions by “80%”. We read each at its source and say below what that source measured. Pages that repeat a number are linked only as dated evidence of how it spread, never as a source for the number. The first two are traced in full on our mental health practice page; here they are short, with the psychiatry angle.

“1 in 5 adults has a mental illness”

It rounds a real federal estimate of a broad measure. A video production company’s page selling video to psychiatrists says that as of 2019, 51.5 million people in the U.S. struggled with mental illness, “one out of every 5 people” (Beverly Boy Productions). That is SAMHSA’s National Survey on Drug Use and Health (NSDUH) count of adults with past-year “any mental illness”. In 2024 it was 23.4% of adults 18 and older (61.5 million) (SAMHSA), from a survey with 56,228 adult interviews (SAMHSA). The series barely moves: 23.0% in 2021, 23.1% in 2022, 22.8% in 2023 and 23.4% in 2024, which SAMHSA labels no change (SAMHSA). No one in the survey is diagnosed: SAMHSA classifies adults with prediction models built from clinical interviews of a subset of NSDUH adults between 2008 and 2012 (SAMHSA). Any mental illness includes mild disorders; serious mental illness in the past year, the subset with serious functional impairment, was 5.6% in 2024 (SAMHSA). NAMI’s wording and the older “one in four” are traced on our mental health practice page.

For psychiatry the subset matters more than the headline. Of the 14.6 million adults with serious mental illness in 2024, 70.8% received some mental health treatment in the past year, counting prescription medication, telehealth and inpatient or outpatient care (SAMHSA), and about 3 in 10, 4.3 million people, received none (SAMHSA). NSDUH does not report how many of them saw a psychiatrist.

Use instead: “23.4% of U.S. adults had any mental illness in the past year and 5.6% had serious mental illness (SAMHSA, NSDUH 2024).”

“Half of all mental illness begins by age 14”

It describes people who ever had a disorder, not everyone, and the word “chronic” was added along the way. In June 2005 HealthDay News reported that about half of all chronic cases began by age 14 (HealthDay). The source, Kessler and colleagues’ 2005 analysis of the 2001-2003 National Comorbidity Survey Replication, counted lifetime cases, not chronic ones: half started by age 14 (Archives of General Psychiatry), among the 46.4% of adults who had ever had a disorder, by recall, and mood disorders, which include depression and bipolar disorder, had a median onset of 30 years (Archives of General Psychiatry). The full trace is on our mental health practice page.

Use instead: a 2022 meta-analysis of 192 studies found 34.6% of people with any mental disorder had onset before 14 (Molecular Psychiatry, Solmi et al.), and only 34.5% of mood disorders began before 25 (Solmi et al.).

“90% of people who die by suicide have a mental illness”

The figure comes from psychological autopsy studies, which assign a diagnosis after a death by interviewing relatives or friends and reading records. AFSP’s “Ask Dr. Jill” column of February 2020, still on its site, says AFSP and other organizations have for years stated that 90% of people who die by suicide have a diagnosable and potentially treatable mental health condition (AFSP), a finding it credits to about 30 studies from around the world (AFSP).

Cavanagh and colleagues’ 2003 systematic review included 76 psychological autopsy studies (Psychological Medicine, Cavanagh et al., PubMed). In the case series, the median share of people with a mental disorder was 91% (Psychological Medicine); in the case-control studies it was 90% of those who died against 27% of living controls (Psychological Medicine), and the share of suicides attributable to mental disorder was 47-74% in the seven studies where it could be calculated (Psychological Medicine). A 2004 meta-analysis of 27 studies covering 3,275 suicides found 87.3% had a mental disorder, counting substance-related problems (BMC Psychiatry, Arsenault-Lapierre et al., PubMed). The share depends on where and how the studies were done. A review of studies from 2000 onward found up to 66.7% of cases had no diagnosis where only major (Axis I) disorders were assessed (International Journal of Social Psychiatry, Milner et al., PubMed), and about 37.1% where personality disorders were also assessed, with a higher share without a diagnosis in parts of China and India than in Europe or North America (Milner et al.). Hjelmeland and colleagues argued in 2012 that the method cannot support the “almost all (90% or more)” figure, because diagnoses come from interviews with a few relatives or friends, often years after the death (Death Studies, Hjelmeland et al., PubMed).

CDC’s June 2018 Vital Signs report measured something else: what death investigators recorded. In 2015 data from 27 states, 54% of people who died by suicide were not known to have a mental health condition (CDC, MMWR, archived), 11,039 people against 9,407 with a known condition (CDC, MMWR, archived). CDC’s public page put it as more than half, 54% (CDC, archived). The 27 states held 49.6% of the U.S. population, the system was not yet nationally representative, and its abstractors see only investigative reports; CDC adds that some of these people likely had conditions that were unknown, undiagnosed or not reported (CDC, MMWR, archived). AFSP’s column says the 54% adds together “no”, “unknown” and missing entries (AFSP).

Use instead: “Reviews of psychological autopsy studies, which reconstruct diagnoses after death, found a mental disorder in a median 91% of cases (Cavanagh et al., 2003); in CDC’s 2015 records from 27 states, 54% of people who died by suicide had no known mental health condition.” Each is true of what it measured.

“Only about half of psychiatrists accept insurance”

It is a 2009-2010 figure about new patients, and the headline version overstates it. On December 12, 2013, KFF Health News’s Morning Briefing headlined the new study “Almost Half Of Psychiatrists Don’t Accept Health Insurance” (KFF Health News). The study, by Bishop and colleagues in JAMA Psychiatry, used the National Ambulatory Medical Care Survey of office-based physicians and asked whether each accepted new patients with each type of coverage. In 2009-2010, 55.3% of psychiatrists accepted new patients with private noncapitated insurance, against 88.7% of other physicians (JAMA Psychiatry, Bishop et al., PubMed); the psychiatrists’ rate had fallen 17.0% since 2005-2006 (Bishop et al.). For Medicare the rates were 54.8% against 86.1% (Bishop et al.), and for Medicaid 43.1% against 73.0% (Bishop et al.). Acceptance of private insurance ranged from 85.1% of psychiatrists in the Midwest to 43.0% in the South, the region that includes Florida (Bishop et al.). The survey covers office-based physicians only, and the abstract reports acceptance by type of coverage, not a share of psychiatrists who take no insurance at all.

A 2024 follow-up by Carlo and colleagues used restricted survey data for 2007-2016, an average of 4,725 physicians per two-year period, about 7% of them psychiatrists, and found psychiatrists joined every type of insurance network at lower rates than other physicians, with the widest gap for Medicare and Medicaid (Psychiatric Services, Carlo et al., PubMed). Its abstract prints no acceptance rates, and Wen and colleagues’ 2019 update on Medicaid acceptance is a research letter with no abstract we could quote.

Use instead: “In 2009-2010, 55.3% of office-based psychiatrists accepted new privately insured patients, 54.8% new Medicare patients and 43.1% new Medicaid patients (Bishop et al., JAMA Psychiatry, 2014).”

“Video lifts conversions 80%”

The figure is a best case from one video vendor, EyeView, about a client website, not psychiatry. In February 2009 EyeView’s blog said viewers of its videos for one client, UMOO, were 80% more likely to become depositing users, comparing viewers with non-viewers (EyeView, archived). By August 2010 Unbounce, a landing-page software seller, wrote that a study by eyeviewdigital.com showed video on landing pages can increase conversion by 80% (Unbounce, archived). A video production company’s page selling video to psychiatrists now says marketing video can “generate increased landing page conversions by 80%”, naming no study (Beverly Boy Productions).

The larger later evidence points the other way. Unbounce’s own 2021 analysis of about 35,000 customer landing pages in each of three periods (Unbounce) concluded that video appears to have a minimal or negative impact on landing-page performance (Unbounce). Its April 2025 article of landing-page examples still says landing pages with video can increase conversions by 80% (Unbounce). We found no conversion test by a psychiatric practice. Use instead: “Unbounce’s 2021 study of about 35,000 landing pages per period found video had a minimal or negative effect; we found no conversion test by a psychiatric practice.”

Every popular claim our research pages trace, 875 in all, is on one page: popular video statistics, fact-checked.

How we built this page

We started from the questions people search for about psychiatrist video statistics and looked for the organization that actually produced each answer. Every figure on this page sits in an evidence ledger with its source, the exact table or paragraph it came from, the measurement period, the population measured, and the date we checked it. This edition holds 549 figures from 56 publishers.

On November 9, 2026, each sourced figure on this page was re-fetched with the fetch cache cleared and matched against the recorded wording: BLS occupation wage estimates and the Quarterly Census of Employment and Wages (through the BLS data API and data files) and Employment Projections and Occupational Outlook pages (through Internet Archive copies, because bls.gov refuses automated requests); Census County Business Patterns, Nonemployer Statistics, the 2022 Economic Census and the Annual Integrated Economic Survey (through the Census data API); Medicare Part B figures through data.cms.gov, within its stated crawl delay; SAMHSA’s NSDUH and N-SUMHSS reports on samhsa.gov; NCHS and CDC reports through Internet Archive copies of cdc.gov (which refuses scripts; its robots file names no AI agent); Florida counts from FLHealthCHARTS and the Florida Department of Health’s physician workforce report; the American Board of Psychiatry and Neurology’s and the AMA’s own pages; the Florida Statutes, Florida Administrative Code, eCFR, GovInfo and the Federal Register; FDA and YouTube Help pages; SEC filings on EDGAR; and journal abstracts (PubMed and PMC records re-read through NCBI’s E-utilities, because the pages answer scripts with a bot check). Our YouTube figures come from the YouTube Data API, our Medicare totals from CMS’s public files, and our filing counts from EDGAR full-text search. We left out sources whose robots rules bar AI agents, among them NAMI (nami.org), data.hrsa.gov, jamanetwork.com and thelancet.com, and read JAMA Psychiatry, Lancet Psychiatry, American Journal of Psychiatry and Psychiatric Services papers only through their PubMed abstracts. We left out sources whose own terms bar use with AI tools or automated collection: the American Psychiatric Association’s psychiatry.org pages (its polls and member surveys), NRMP’s Match reports, and the ABMS, ACGME and AAMC sites. We could not read bhw.hrsa.gov, hhs.gov or dea.gov (403), so there are no HRSA shortage-area counts and DEA rules are cited through the Federal Register. Medical subject matter is reported as each source states it. Nothing here is medical advice.

We only cite the producer: government agencies, regulators, company filings and official posts, and the survey owner's own report. We do not cite statistics roundups, Statista-style aggregators, or salary sites without a public method. We did not bypass paywalls or sign-up forms; where a full report was gated, we used only the figures its publisher states publicly.

Figures marked "our calculation" are arithmetic on the cited numbers, and anyone can reproduce them:

This edition contains no Mark Studios customer data.

Limitations

• No single count of psychiatrists exists. BLS counts wage and salary jobs, its projections add the self-employed, the board counts active certificates, a 2025 study counts professionally active psychiatrists, and CMS counts providers who billed original Medicare. They differ by more than two to one, and we print them side by side rather than choose one.
• Medicare is one slice of psychiatry. Original Medicare covers mostly people 65 and older and people with disabilities. The Part B file has no Medicare Advantage, no Medicaid and no private insurance, drops lines with fewer than 11 patients, and cannot separate video visits from office visits. Psychiatric nurse practitioners bill under a separate provider type. Payment comparisons are before inflation.
• BLS has no psychiatrist figures below the Miami metro area. OEWS publishes no psychiatrist series for the West Palm Beach, Fort Lauderdale or Miami divisions, for the Port St. Lucie area or for counties, and none for psychiatric hospitals. NAICS 621112 covers offices of mental health physicians, all staff included; advertising figures cover all physician offices and are labelled as shared.
• NSDUH does not count psychiatrist visits on their own. Its closest category is treatment in the office of a therapist, psychologist, psychiatrist or other mental health professional. Its mental illness measures come from statistical models, not diagnoses, and its 2024 response rate was 11.3%.
• Most video studies are one search on one day. YouTube, TikTok and Douyin content studies score top results for a short list of terms, often in one language, with different quality scales. Their shares are spreads across samples, not a rate for all psychiatry video.
• Trials and telehealth studies vary in design. Some video trials found no difference on their main outcome, and telehealth shares depend on the payer and the years. We report what each study measured and promise nothing about any treatment, medication, program or practice.
• Our YouTube read follows YouTube’s ranking. The 571 videos are what YouTube’s search returned for three terms (the top 200 results of each, sorted by views, with no country filter) on November 9, 2026. It is not a census of psychiatry video. View counts are lifetime snapshots, and we sorted 386 channels by hand from their public text; credentials were not checked. Personal and family stories, children and some counted-only material are published only as a class and counts, so 16.5% of on-topic views cannot be recomputed from the public CSV.
• Filings count words. EDGAR full-text search finds a word, not a topic. We read the passages around the word in the 54 filings from 2022 on that also mention video; other filings are counts only.
• Rules are dated. Statutes and rules are reported as we read them on November 9, 2026. DEA’s telemedicine flexibilities run through December 31, 2026 unless extended again. This is not legal advice. Every “earliest we found” in the origins section rests on web pages, PubMed and the Internet Archive; newspaper databases were not searched.

How to cite this page

For a single figure, cite the original publisher named next to it, and link here if the verification trail is useful to your readers. Each figure has its own anchor, so you can link straight to it, for example https://www.markstudios.com/research/psychiatrist-video-statistics#DRV-219. To cite the page as a whole:

Mark Studios. "Psychiatrist Video Statistics." Last verified Nov 9, 2026. https://www.markstudios.com/research/psychiatrist-video-statistics

@misc{markstudios_psychiatrist_video_statistics_2026,
  author = {{Mark Studios}},
  title = {{Psychiatrist Video Statistics}},
  year = {2026},
  month = nov,
  url = {https://www.markstudios.com/research/psychiatrist-video-statistics},
  note = {Last verified 2026-11-09}
}

Our calculations and the evidence table are free to reuse with attribution and a link to this page. Each underlying figure remains the claim of its original publisher, and some publishers ask for a link when their figures are reused.

Sources

Download the evidence table (CSV)

1. Canadian Journal of Psychiatry (Yeung et al.), TikTok and Attention-Deficit/Hyperactivity Disorder: A Cross-Sectional Study of Social Media Content Quality (2022-02-23). Accessed 2026-11-09.
2. JMIR Infodemiology (Sieferle et al.), Quality and Perception of Attention-Deficit/Hyperactivity Disorder Content on TikTok: Cross-Sectional Study (2025-11-13). Accessed 2026-11-09.
3. Australasian Psychiatry (Verma et al.), How evidence-based is the "hashtag ADHD test" (#adhdtest). A cross-sectional content analysis of TikTok videos on attention-deficit/hyperactivity disorder (ADHD) screening (2024-10-18). Accessed 2026-11-09.
4. BMC Research Notes (Thapa et al.), YouTube lens to attention deficit hyperactivity disorder: a social media analysis (2018-12-04). Accessed 2026-11-09.
5. Psychiatric Services (Nour et al.), Schizophrenia on YouTube (2016-08-15). Accessed 2026-11-09.
6. JMIR Infodemiology (Rainer et al.), Portrayals of Depression on TikTok: Content Analysis of Diagnostic Accuracy, Creator Type, and Stylistic Features (2026-04-13). Accessed 2026-11-09.
7. Journal of Mental Health (Gogoi et al.), Exposing the essence: evaluating quality, readability, trustworthiness, and understandability of information on depression in YouTube videos and the web (2025-06-02). Accessed 2026-11-09.
8. BMC Research Notes (Thapa et al.), YouTube lens to attention deficit hyperactivity disorder: a social media analysis (2018-12-04). Accessed 2026-11-09.
9. National Medical Journal of India (Iqbal et al.), Quality and reliability of YouTube videos on attention deficit hyperactivity disorder: A cross-sectional study (2026-05-01). Accessed 2026-11-09.
10. Scientific Reports (Lin et al.), The quality and reliability of short videos about depression on TikTok (Douyin): a cross-sectional study (2026-03-21). Accessed 2026-11-09.
11. Frontiers in Public Health (Wang et al.), Information quality of videos related to adolescent depression on social media platforms: a comparative study of TikTok and BiliBili (2025-11-19). Accessed 2026-11-09.
12. Saudi Pharmaceutical Journal (Alsabhan et al.), A content-quality and optimization analysis of YouTube as a source of patient information for bipolar disorder (2024-02-20). Accessed 2026-11-09.
13. Scientific Reports (Zhang et al.), Evaluation of the content and quality of schizophrenia on TikTok: a cross-sectional study (2024-11-02). Accessed 2026-11-09.
14. Digital Health (Yu et al.), Evaluating the quality, reliability, and diagnostic risk of ADHD content on TikTok and Bilibili: A cross-sectional content analysis (2026-03-24). Accessed 2026-11-09.
15. Journal of Adolescent Health (Samuel et al.), TherapyTok for Depression and Anxiety: A Quantitative Content Analysis of High Engagement TikTok Videos (2024-03-15). Accessed 2026-11-09.
16. Journal of Attention Disorders (Johnson et al.), Content Analysis of the Portrayal of Prescription Stimulants on TikTok (2025-02-18). Accessed 2026-11-09.
17. JMIR Mental Health (Quinn et al.), Dissemination of Information on Selective Serotonin Reuptake Inhibitors on TikTok: Analytical Mixed Methods Study of Creator Types, Content Tone, and User Engagement (2025-09-30). Accessed 2026-11-09.
18. British Journal of Psychiatry (Hagi et al.), Telepsychiatry versus face-to-face treatment: systematic review and meta-analysis of randomised controlled trials (2023-09-01). Accessed 2026-11-09.
19. Psychiatric Services (O'Reilly et al.), Is telepsychiatry equivalent to face-to-face psychiatry? Results from a randomized controlled equivalence trial (2007-06-01). Accessed 2026-11-09.
20. American Journal of Psychiatry (Ruskin et al.), Treatment outcomes in depression: comparison of remote treatment through telepsychiatry to in-person treatment (2004-08-01). Accessed 2026-11-09.
21. American Journal of Psychiatry (Fortney et al.), Practice-based versus telemedicine-based collaborative care for depression in rural federally qualified health centers: a pragmatic randomized comparative effectiveness trial (2013-04-01). Accessed 2026-11-09.
22. JAMA Psychiatry (Fortney et al.), Comparison of Teleintegrated Care and Telereferral Care for Treating Complex Psychiatric Disorders in Primary Care: A Pragmatic Randomized Comparative Effectiveness Trial (2021-11-01). Accessed 2026-11-09.
23. Journal of the American Academy of Child and Adolescent Psychiatry (Myers et al.), Effectiveness of a telehealth service delivery model for treating attention-deficit/hyperactivity disorder: a community-based randomized controlled trial (2015-01-29). Accessed 2026-11-09.
24. Early Intervention in Psychiatry (Zhou et al.), Effectiveness of video-based psychiatric rehabilitation for patients with early-phase schizophrenia spectrum: A randomized controlled trial (2024-05-23). Accessed 2026-11-09.
25. JAMA Health Forum (Wilcock et al.), Use of Telemedicine and Quality of Care Among Medicare Enrollees With Serious Mental Illness (2023-10-06). Accessed 2026-11-09.
26. The Permanente Journal (Metrikin et al.), Comparing In-Person, Telephonic, and Video-Based Treatment of Depression in Adult Primary Care During the COVID-19 Pandemic (2024-12-05). Accessed 2026-11-09.
27. JAMA Network Open (Tenso et al.), Virtual Mental Health Care and Suicide-Related Events (2024-11-04). Accessed 2026-11-09.
28. Health Affairs Scholar (Song et al.), Telehealth and the work behavior of mental health clinicians (2026-03-25). Accessed 2026-11-09.
29. JAMA Network Open (McBain et al.), Telehealth vs In-Person Outpatient Mental Health Service Use and Spending Among Medicare Beneficiaries From 2019 to 2023 (2026-01-02). Accessed 2026-11-09.
30. JAMA Psychiatry (Olfson et al.), Telemental Health, Hybrid, and In-Person Outpatient Mental Health Care in the US (2026-01-01). Accessed 2026-11-09.
31. Psychiatric Services (Sowa et al.), Modality of Behavioral Health Care Delivery in Commercial Claims: Implications for Telehealth Policy (2026-05-12). Accessed 2026-11-09.
32. JAMA Health Forum (Hailu et al.), Characteristics of Mental Health Specialists Who Shifted Their Practice Entirely to Telemedicine (2024-01-05). Accessed 2026-11-09.
33. JAMA Network Open (Jorem et al.), Mental Health Specialist Telemedicine Uptake and Patient Location (2026-03-02). Accessed 2026-11-09.
34. Psychiatric Services (Tsai et al.), A Randomized Controlled Trial of Video Psychoeducation for Electroconvulsive Therapy in the United States (2020-03-10). Accessed 2026-11-09.
35. American Journal of Psychiatry (Amsalem et al.), Sustained Effect of a Brief Video in Reducing Public Stigma Toward Individuals With Psychosis: A Randomized Controlled Trial of Young Adults (2021-04-26). Accessed 2026-11-09.
36. Early Intervention in Psychiatry (Dondé et al.), Exploring the Effect of Brief Preventive Videos on Mental Health Help-Seeking for Early Psychosis in a Young Community Sample (2025-02-01). Accessed 2026-11-09.
37. Patient Education and Counseling (Sleath et al.), A pre-visit video/question prompt list intervention to increase youth question-asking about attention deficit hyperactivity disorder during pediatric visits (2024-05-31). Accessed 2026-11-09.
38. American Board of Psychiatry and Neurology, Certifications - Total and Active (as of December 31, 2025) (2026). Accessed 2026-11-09.
39. JAMA Network Open (Havlik et al., Stanford University), Trends in Psychiatrist-Led Care for Medicare Part B Enrollees (2025-02-03). Accessed 2026-11-09.
40. Florida Department of Health, Florida Physician Workforce 2026 Annual Report (2026-11-01). Accessed 2026-11-09.
41. American Board of Psychiatry and Neurology, Facts and Statistics (2026). Accessed 2026-11-09.
42. Psychiatric Services (Silvestre et al.), The Impending Psychiatrist Shortage: Projected Deficiencies in the U.S. Adult Psychiatry Workforce (2026-05-06). Accessed 2026-11-09.
43. Academic Psychiatry (Silvestre et al.), Projected Deficiencies in the Child and Adolescent Psychiatrist Workforce in the USA: A Call to Action (2026-06-26). Accessed 2026-11-09.
44. Medical Care (Tadmon and Gao), Factors Associated With Psychotherapist and Psychiatrist Participation in Public Insurance: Evidence From Georgia State (2024-11-12). Accessed 2026-11-09.
45. Psychiatric Services (Chen et al., Baylor College of Medicine), Availability of Outpatient Child Psychiatric Care During COVID-19: A Simulated-Patient Study in Three U.S. Cities (2023-06-08). Accessed 2026-11-09.
46. Substance Abuse and Mental Health Services Administration (SAMHSA), National Substance Use and Mental Health Services Survey (N-SUMHSS), 2025: Annual Detailed Tables (2026-10). Accessed 2026-11-09.
47. American Medical Association (Physician Practice Benchmark Survey), Patient-Facing Telehealth: Use Is Higher Than Pre-Pandemic But With Great Variation Across Physician Specialties (Policy Research Perspectives) (2025-11). Accessed 2026-11-09.
48. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-09.
49. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2019 data) (2025-03-26). Accessed 2026-11-09.
50. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2023 data) (2025-09-09). Accessed 2026-11-09.
51. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-09.
52. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2019 data) (2025-03-26). Accessed 2026-11-09.
53. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-09.
54. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2019 data) (2025-03-26). Accessed 2026-11-09.
55. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-09.
56. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2019 data) (2025-03-26). Accessed 2026-11-09.
57. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2019 data) (2025-03-26). Accessed 2026-11-09.
58. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-09.
59. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2019 data) (2025-03-26). Accessed 2026-11-09.
60. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-09.
61. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2024 data) (2026-05-21). Accessed 2026-11-09.
62. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2019 data) (2023-05-10). Accessed 2026-11-09.
63. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
64. U.S. Bureau of Labor Statistics, Occupational Outlook Handbook: Physicians and Surgeons (2026-08-27). Accessed 2026-11-09.
65. U.S. Bureau of Labor Statistics, Employment Projections, Table 1.2: Occupational projections, 2025-35, and worker characteristics, 2025 (2026-08-27). Accessed 2026-11-09.
66. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
67. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
68. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
69. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
70. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
71. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
72. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
73. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
74. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
75. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
76. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
77. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
78. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-09.
79. U.S. Bureau of Labor Statistics, QCEW open data, 2025 annual averages, industry 621112 (2026-09-03). Accessed 2026-11-09.
80. U.S. Bureau of Labor Statistics, QCEW open data, 2015 annual averages, industry 621112 (not stated in CSV (2015 annual file)). Accessed 2026-11-09.
81. U.S. Census Bureau, County Business Patterns 2023 (Census Data API, cbp) (2025-06-26). Accessed 2026-11-09.
82. U.S. Census Bureau, 2022 Economic Census: Selected Statistics by Industry (ecnbasic) (2025-01-23). Accessed 2026-11-09.
83. U.S. Census Bureau, Nonemployer Statistics 2024 (Census Data API, nonemp) (not stated in API response). Accessed 2026-11-09.
84. U.S. Census Bureau, Nonemployer Statistics 2023 (Census Data API, nonemp) (not stated in API response). Accessed 2026-11-09.
85. U.S. Census Bureau, County Business Patterns 2023 (Census Data API, cbp) (2025-06-26). Accessed 2026-11-09.
86. U.S. Census Bureau, County Business Patterns 2023 (Census Data API, cbp) (2025-06-26). Accessed 2026-11-09.
87. U.S. Census Bureau, 2022 Economic Census: Telemedicine Services by Industry (ecntelemeds) (2025-01-23). Accessed 2026-11-09.
88. U.S. Census Bureau, Annual Integrated Economic Survey: Detailed Operating Expenses: 2024 (aiesexp02) (2026-05-28). Accessed 2026-11-09.
89. Substance Abuse and Mental Health Services Administration (SAMHSA), Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (2025-07). Accessed 2026-11-09.
90. National Center for Health Statistics (CDC), Mental Health Treatment Among Adults: United States, 2024 (NCHS Data Brief No. 564) (2026-06). Accessed 2026-11-09.
91. National Center for Health Statistics (CDC), Antidepressant Use Among Adults: United States, 2015-2018 (NCHS Data Brief No. 377) (2020-09). Accessed 2026-11-09.
92. National Center for Health Statistics (CDC), Depression Prevalence in Adolescents and Adults: United States, August 2021-August 2023 (NCHS Data Brief No. 527) (2025-04). Accessed 2026-11-09.
93. Substance Abuse and Mental Health Services Administration (SAMHSA), National Survey on Drug Use and Health: 2023-2024 State-Specific Tables of Model-Based Estimates (Totals and Percentages) (2026-02-04). Accessed 2026-11-09.
94. Centers for Disease Control and Prevention (CDC), citing HRSA's National Survey of Children's Health, Data on ADHD in Children (2026-07-08). Accessed 2026-11-09.
95. CDC, Morbidity and Mortality Weekly Report (Staley et al.), Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults - National Center for Health Statistics Rapid Surveys System, United States, October-November 2023 (2024-10-10). Accessed 2026-11-09.
96. National Center for Health Statistics (CDC), Changes in Suicide Rates in the United States From 2023 to 2024 (NCHS Data Brief No. 572) (2026-09). Accessed 2026-11-09.
97. Florida Department of Health (FLHealthCHARTS, Bureau of Vital Statistics), Deaths From Suicide (FLHealthCHARTS death indicator, Florida selected) (2026). Accessed 2026-11-09.
98. Florida Department of Health (FLHealthCHARTS, Bureau of Vital Statistics), Deaths From Suicide (FLHealthCHARTS death indicator, Broward County selected) (2026). Accessed 2026-11-09.
99. Florida Department of Health (FLHealthCHARTS, Bureau of Vital Statistics), Deaths From Suicide (FLHealthCHARTS death indicator, Martin County selected) (2026). Accessed 2026-11-09.
100. LifeStance Health Group, Inc., LifeStance Health Group, Inc. Form 10-K for fiscal year 2025 (2026-02-25). Accessed 2026-11-09.
101. Talkspace, Inc., Talkspace, Inc. Form 10-K for fiscal year 2025 (2026-03-13). Accessed 2026-11-09.
102. Teladoc Health, Inc., Teladoc Health, Inc. Form 10-K for fiscal year 2025 (2026-02-26). Accessed 2026-11-09.
103. Acadia Healthcare Company, Inc., Acadia Healthcare Company, Inc. Form 10-K for fiscal year 2025 (2026-02-27). Accessed 2026-11-09.
104. Universal Health Services, Inc., Universal Health Services, Inc. Form 10-K for fiscal year 2025 (2026-02-25). Accessed 2026-11-09.
105. Neuronetics, Inc., Neuronetics, Inc. Form 10-K for fiscal year 2025 (2026-03-17). Accessed 2026-11-09.
106. Johnson & Johnson, Johnson & Johnson Form 10-K for fiscal year 2025 (ended December 28, 2025) (2026-02-11). Accessed 2026-11-09.
107. Axsome Therapeutics, Inc., Axsome Therapeutics, Inc. Form 10-K for fiscal year 2025 (2026-02-23). Accessed 2026-11-09.
108. Neurocrine Biosciences, Inc., Neurocrine Biosciences, Inc. Form 10-K for fiscal year 2025 (2026-02-11). Accessed 2026-11-09.
109. Alkermes plc, Alkermes plc Form 10-K for fiscal year 2025 (2026-02-25). Accessed 2026-11-09.
110. American Well Corporation, American Well Corporation Form 10-K for fiscal year 2025 (2026-02-12). Accessed 2026-11-09.
111. Hims & Hers Health, Inc., Hims & Hers Health, Inc. Form 10-K for fiscal year 2025 (2026-02-23). Accessed 2026-11-09.
112. Supernus Pharmaceuticals, Inc., Supernus Pharmaceuticals, Inc. Form 10-K for fiscal year 2025 (2026-03-02). Accessed 2026-11-09.
113. Drug Enforcement Administration and HHS (Federal Register), Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (90 FR 61301) (2025-12-31). Accessed 2026-11-09.
114. U.S. Congress (Public Law 110-425, via GovInfo), Public Law 110-425: Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (2008-10-15). Accessed 2026-11-09.
115. Drug Enforcement Administration and HHS (Federal Register), Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (88 FR 30037) (2023-05-10). Accessed 2026-11-09.
116. Drug Enforcement Administration and HHS (Federal Register), Second Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (88 FR 69879) (2023-10-10). Accessed 2026-11-09.
117. Drug Enforcement Administration and HHS (Federal Register), Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (89 FR 91253) (2024-11-19). Accessed 2026-11-09.
118. Drug Enforcement Administration and HHS (Federal Register), Special Registrations for Telemedicine and Limited State Telemedicine Registrations (proposed rule, 90 FR 6541) (2025-01-17). Accessed 2026-11-09.
119. Department of Justice, Drug Enforcement Administration (Unified Agenda, Federal Register), Introduction to the Unified Agenda of Federal Regulatory and Deregulatory Actions-2026 (Regulatory Plan entry 90) (2026-08-14). Accessed 2026-11-09.
120. Drug Enforcement Administration and HHS (Federal Register), Expansion of Buprenorphine Treatment via Telemedicine Encounter (final rule, 90 FR 6504) (2025-01-17). Accessed 2026-11-09.
121. Drug Enforcement Administration and HHS (Federal Register), Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients; Delay of Effective Date (2025-03-24). Accessed 2026-11-09.
122. The Florida Legislature, The 2026 Florida Statutes, 456.47 Use of telehealth to provide services (2026). Accessed 2026-11-09.
123. Florida Legislature (Online Sunshine), Florida Statutes 456.44 Controlled substance prescribing (2026). Accessed 2026-11-09.
124. Florida Legislature (Online Sunshine), Florida Statutes 394.463 Involuntary examination (2026). Accessed 2026-11-09.
125. Florida Department of State (Florida Administrative Code), Rule: 64B8-11.001 Advertising (2026-03-19). Accessed 2026-11-09.
126. Florida Department of State (Florida Administrative Code), Board of Medicine rule, 64B8-11.001 Advertising (rule text) (2026-03-19). Accessed 2026-11-09.
127. The Florida Legislature, The 2026 Florida Statutes, 456.072 Grounds for discipline; penalties; enforcement (2026). Accessed 2026-11-09.
128. U.S. Department of Health and Human Services (rule text via eCFR), 45 CFR 164.501 -- Definitions (2026-11-05). Accessed 2026-11-09.
129. U.S. Department of Health and Human Services, Office for Civil Rights, 45 CFR 164.508 - Uses and disclosures for which an authorization is required (eCFR) (2026-11-05). Accessed 2026-11-09.
130. U.S. Department of Health and Human Services (rule text via eCFR), 45 CFR 164.524 -- Access of individuals to protected health information (2026-11-05). Accessed 2026-11-09.
131. U.S. Department of Health and Human Services (Federal Register), Confidentiality of Substance Use Disorder (SUD) Patient Records (final rule, 89 FR 12472) (2024-02-16). Accessed 2026-11-09.
132. Federal Trade Commission (Federal Register), Guides Concerning the Use of Endorsements and Testimonials in Advertising (88 FR 48092) (2023-07-26). Accessed 2026-11-09.
133. Federal Trade Commission (rule text via eCFR, Office of the Federal Register), 16 CFR Part 255 -- Guides Concerning Use of Endorsements and Testimonials in Advertising (2023-07-26). Accessed 2026-11-09.
134. U.S. Food and Drug Administration (rule text via eCFR, Office of the Federal Register), 21 CFR 202.1 -- Prescription-drug advertisements (2026-11-05). Accessed 2026-11-09.
135. U.S. Food and Drug Administration (Federal Register), Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format (2023-11-21). Accessed 2026-11-09.
136. U.S. Department of Health and Human Services (rule text via eCFR, Office of the Federal Register), 45 CFR 102.3 -- Penalty adjustment and table (2026-11-05). Accessed 2026-11-09.
137. U.S. Food and Drug Administration, New Warnings Proposed for Antidepressants (FDA Consumer Update, May 2007) (2007-05-03). Accessed 2026-11-09.
138. U.S. Food and Drug Administration, FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions (Drug Safety Communication) (2023-05-11). Accessed 2026-11-09.
139. Centers for Medicare & Medicaid Services (Federal Register), Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies (final rule, 91 FR 70992) (2026-11-09). Accessed 2026-11-09.
140. Centers for Medicare & Medicaid Services (rule text via eCFR), 42 CFR 410.78 -- Telehealth services (2026-11-05). Accessed 2026-11-09.
141. YouTube (Google), platform owner, Suicide, self-harm, and eating disorders policy - YouTube Help (2026-11-09). Accessed 2026-11-09.
142. YouTube (Google), Medical misinformation policy - YouTube Help (2026-11-09). Accessed 2026-11-09.
143. YouTube (Google), Apply to be a source in YouTube health features - YouTube Help (2026-11-09). Accessed 2026-11-09.
144. Beverly Boy Productions (video production company; sells video to psychiatrists), Video Production for Psychiatrists (2022-08-17). Accessed 2026-11-09.
145. HealthDay News (consumer health news service), Mental Illness Affects Many (2005-06-06). Accessed 2026-11-09.
146. Archives of General Psychiatry (Kessler et al., Harvard Medical School), Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication (2005-06). Accessed 2026-11-09.
147. Molecular Psychiatry (Solmi et al.), Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies (2022-01). Accessed 2026-11-09.
148. American Foundation for Suicide Prevention (AFSP; nonprofit, does not sell treatment), Ask Dr. Jill: Does Mental Illness Play a Role in Suicide? (2020-02-07). Accessed 2026-11-09.
149. Psychological Medicine (Cavanagh et al., University of Glasgow), Psychological autopsy studies of suicide: a systematic review (2003-04). Accessed 2026-11-09.
150. BMC Psychiatry (Arsenault-Lapierre et al., McGill University), Psychiatric diagnoses in 3275 suicides: a meta-analysis (2004-11-04). Accessed 2026-11-09.
151. International Journal of Social Psychiatry (Milner et al., Griffith University), Suicide in the absence of mental disorder? A review of psychological autopsy studies across countries (2013-09). Accessed 2026-11-09.
152. Death Studies (Hjelmeland et al., Norwegian University of Science and Technology), Psychological autopsy studies as diagnostic tools: are they methodologically flawed? (2012-08). Accessed 2026-11-09.
153. Centers for Disease Control and Prevention (CDC), MMWR (Stone et al.), Vital Signs: Trends in State Suicide Rates - United States, 1999-2016 and Circumstances Contributing to Suicide - 27 States, 2015 (2018-06-08). Accessed 2026-11-09.
154. Centers for Disease Control and Prevention (CDC), Vital Signs: Suicide rising across the US (2018-06). Accessed 2026-11-09.
155. KFF Health News (news service; Morning Briefing summarizes other outlets), Study: Almost Half Of Psychiatrists Don't Accept Health Insurance (2013-12-12). Accessed 2026-11-09.
156. JAMA Psychiatry (Bishop et al., Weill Cornell Medical College), Acceptance of insurance by psychiatrists and the implications for access to mental health care (2014-02). Accessed 2026-11-09.
157. Psychiatric Services (Carlo et al.), Acceptance of Insurance by Psychiatrists and Other Physicians, 2007-2016 (2024-01-01). Accessed 2026-11-09.
158. EyeView Digital (video production and testing vendor; sold the videos it tested), UMOO - a prime beef example of EyeView's success (2009-02-10). Accessed 2026-11-09.
159. Unbounce (landing-page software seller), The benefits of using video on landing pages (2010-08). Accessed 2026-11-09.
160. Unbounce (landing-page software seller; analysis of its own customers' pages), Video on landing pages means more conversions, right? Wrong. Here's why (2021-08-26). Accessed 2026-11-09.
161. Unbounce (landing-page software seller; repeater), 15 high-converting landing page examples (+ why they work) (2025-04-06). Accessed 2026-11-09.

Update policy and change log

We re-verify every figure quarterly and when a major source publishes a new edition. The next scheduled review is February 2027. Corrections go to contact@markstudios.com.

• Nov 9, 2026: First published with 549 figures from 56 publishers, each checked against its original source.